Literature DB >> 25080851

Brain differences in first-episode schizophrenia treated with quetiapine: a deformation-based morphometric study.

Chunlan Yang1, Shuicai Wu, Wangsheng Lu, Yanping Bai, Hongjian Gao.   

Abstract

RATIONALE: With the development of various imaging techniques, the deformation-based morphometry (DBM) method provides an objective automatic examination of the whole brain.
OBJECTIVES: This study aims to assess the abnormalities in the brains of first-episode schizophrenia (FES) patients treated with quetiapine using another advanced nonrigid registration method, hierarchical attribute matching mechanism for elastic registration, through the application of DBM in the entire brain.
METHODS: Thirty FES patients and 30 normal controls were grouped by age and handedness and subjected to magnetic resonance imaging examination. The patients had relatively short durations of untreated psychosis (DUP; 6.4 ± 5.2 months), and only a single antipsychotic drug, quetiapine (dosage, 200 ± 75 mg), was used for treatment. Statistically significant changes in regional volume were analyzed via DBM. In addition, a voxel-wise analysis of correlations between the duration of treatment or dosage and volume was also performed.
RESULTS: Compared with control subjects, FES patients showed contracted regions located in Brodmann area (BA) 42 and BA 19. By contrast, expanded regions were observed in BA 38, BA 21, BA 6 and 8, and left cerebellum. A negative correlation was observed between dosage and volume in the hippocampus, while a positive correlation was found in the caudate. Meanwhile, a negative correlation was observed between duration of treatment and volume in BA 38.
CONCLUSION: Both regional volume reductions and increases were detected in the brains of FES patients treated with quetiapine compared with healthy control subjects. Such differences may be partially relevant to dosage and treatment duration in clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25080851     DOI: 10.1007/s00213-014-3670-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  Hippocampal and amygdala volume reductions in first-episode schizophrenia.

Authors:  A Vita; L de Peri
Journal:  Br J Psychiatry       Date:  2007-03       Impact factor: 9.319

Review 2.  The role of the cerebellum in schizophrenia.

Authors:  Nancy C Andreasen; Ronald Pierson
Journal:  Biol Psychiatry       Date:  2008-04-08       Impact factor: 13.382

Review 3.  Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.

Authors:  R Grant Steen; Courtney Mull; Robert McClure; Robert M Hamer; Jeffrey A Lieberman
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

4.  The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.

Authors:  Takashi Ohnishi; Ryota Hashimoto; Takeyuki Mori; Kiyotaka Nemoto; Yoshiya Moriguchi; Hidehiro Iida; Hiroko Noguchi; Tetsuo Nakabayashi; Hiroaki Hori; Mayu Ohmori; Ryoutaro Tsukue; Kimitaka Anami; Naotugu Hirabayashi; Seiichi Harada; Kunimasa Arima; Osamu Saitoh; Hiroshi Kunugi
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

5.  Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms.

Authors:  Bjørn H Ebdrup; Arnold Skimminge; Hans Rasmussen; Bodil Aggernaes; Bob Oranje; Henrik Lublin; William Baaré; Birte Glenthøj
Journal:  Int J Neuropsychopharmacol       Date:  2010-08-12       Impact factor: 5.176

6.  Detecting structural changes in whole brain based on nonlinear deformations-application to schizophrenia research.

Authors:  C Gaser; H P Volz; S Kiebel; S Riehemann; H Sauer
Journal:  Neuroimage       Date:  1999-08       Impact factor: 6.556

7.  Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study.

Authors:  Thomas J Whitford; Stuart M Grieve; Tom F D Farrow; Lavier Gomes; John Brennan; Anthony W F Harris; Evian Gordon; Leanne M Williams
Journal:  Neuroimage       Date:  2006-05-03       Impact factor: 6.556

8.  Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesco Bedogni; Massimo Gennarelli; Jorge Perez; Giorgio Racagni; Marco A Riva
Journal:  Neuroreport       Date:  2004-09-15       Impact factor: 1.837

9.  Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine.

Authors:  Benedicto Crespo-Facorro; Roberto Roiz-Santiáñez; Rocío Pérez-Iglesias; José M Pelayo-Terán; José M Rodríguez-Sánchez; Diana Tordesillas-Gutiérrez; MariLuz Ramírez; Obdulia Martínez; Agustin Gutiérrez; Enrique Marco de Lucas; José L Vázquez-Barquero
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-10-07       Impact factor: 5.067

10.  Parcellation of human temporal polar cortex: a combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers.

Authors:  Song-Lin Ding; Gary W Van Hoesen; Martin D Cassell; Amy Poremba
Journal:  J Comp Neurol       Date:  2009-06-20       Impact factor: 3.215

View more
  4 in total

1.  Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume.

Authors:  M Berk; O Dandash; R Daglas; S M Cotton; K Allott; A Fornito; C Suo; P Klauser; B Liberg; L Henry; C Macneil; M Hasty; P McGorry; C Pantelis; M Yücel
Journal:  Transl Psychiatry       Date:  2017-01-24       Impact factor: 6.222

2.  Verbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis.

Authors:  Mathilde Antoniades; Tabea Schoeler; Joaquim Radua; Isabel Valli; Paul Allen; Matthew J Kempton; Philip McGuire
Journal:  Neurosci Biobehav Rev       Date:  2017-12-06       Impact factor: 8.989

3.  Volume alteration of hippocampal subfields in first-episode antipsychotic-naïve schizophrenia patients before and after acute antipsychotic treatment.

Authors:  Wenbin Li; Kaiming Li; Pujun Guan; Ying Chen; Yuan Xiao; Su Lui; John A Sweeney; Qiyong Gong
Journal:  Neuroimage Clin       Date:  2018-07-10       Impact factor: 4.881

4.  Reduced Hippocampal Subfield Volume in Schizophrenia and Clinical High-Risk State for Psychosis.

Authors:  Daiki Sasabayashi; Ryo Yoshimura; Tsutomu Takahashi; Yoichiro Takayanagi; Shimako Nishiyama; Yuko Higuchi; Yuko Mizukami; Atsushi Furuichi; Mikio Kido; Mihoko Nakamura; Kyo Noguchi; Michio Suzuki
Journal:  Front Psychiatry       Date:  2021-03-22       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.